300 related articles for article (PubMed ID: 22920343)
1. Spectrum of gastric malignancy on 18F-FDG PET/CT: a pictorial essay.
Makis W; Ciarallo A; Hickeson M; Rush C; Derbekyan V; Novales-Diaz JA; Laufer J; Stern J; Lisbona R
Clin Imaging; 2012; 36(5):432-46. PubMed ID: 22920343
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of malignant pleural and pericardial disease on FDG PET/CT.
Makis W; Ciarallo A; Hickeson M; Rush C; Novales-Diaz JA; Derbekyan V; Laufer J; Stern J; Lisbona R
AJR Am J Roentgenol; 2012 Mar; 198(3):678-85. PubMed ID: 22358009
[TBL] [Abstract][Full Text] [Related]
3. Spectrum of malignant renal and urinary bladder tumors on 18F-FDG PET/CT: a pictorial essay.
Makis W; Ciarallo A; Rakheja R; Probst S; Hickeson M; Rush C; Novales-Diaz JA; Derbekyan V; Stern J; Lisbona R
Clin Imaging; 2012; 36(6):660-73. PubMed ID: 23153993
[TBL] [Abstract][Full Text] [Related]
4. A prospective evaluation of the utility of 2-deoxy-2-[(18) F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer.
Smyth E; Schöder H; Strong VE; Capanu M; Kelsen DP; Coit DG; Shah MA
Cancer; 2012 Nov; 118(22):5481-8. PubMed ID: 22549558
[TBL] [Abstract][Full Text] [Related]
5. [18F]Fluorodeoxyglucose PET/Computed Tomography in Gastrointestinal Malignancies.
Donswijk ML; Hess S; Mulders T; Lam MG
PET Clin; 2014 Oct; 9(4):421-41, v-vi. PubMed ID: 26050945
[TBL] [Abstract][Full Text] [Related]
6. PET/Computed Tomography in the Diagnosis and Staging of Gastric Cancers.
Malibari N; Hickeson M; Lisbona R
PET Clin; 2015 Jul; 10(3):311-26. PubMed ID: 26099669
[TBL] [Abstract][Full Text] [Related]
7. Incremental diagnostic utility of gastric distension FDG PET/CT.
Le Roux PY; Duong CP; Cabalag CS; Parameswaran BK; Callahan J; Hicks RJ
Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):644-53. PubMed ID: 26487512
[TBL] [Abstract][Full Text] [Related]
8. The use of ¹⁸F-FDG PET/CT in Cowden syndrome to differentiate multifocal gastric carcinoma from extensive benign gastric polyposis.
Makis W; Ciarallo A; Hickeson M
Clin Nucl Med; 2012 Mar; 37(3):311-4. PubMed ID: 22310267
[No Abstract] [Full Text] [Related]
9. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS
Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
[TBL] [Abstract][Full Text] [Related]
10. Spectrum of Physiologic and Pathologic Skeletal Muscle (18)F-FDG Uptake on PET/CT.
Karunanithi S; Soundararajan R; Sharma P; Naswa N; Bal C; Kumar R
AJR Am J Roentgenol; 2015 Aug; 205(2):W141-9. PubMed ID: 26001118
[TBL] [Abstract][Full Text] [Related]
11. Gastric Carcinosarcoma and 18F-FDG PET/CT.
Li B; Zhang Y; Hou J; Cai L; Zhou J; Shi H
Clin Nucl Med; 2015 Nov; 40(11):e506-7. PubMed ID: 26359557
[TBL] [Abstract][Full Text] [Related]
12. Performance of (18)F-FDG PET/CT as a postoperative surveillance imaging modality for asymptomatic advanced gastric cancer patients.
Lee DY; Lee CH; Seo MJ; Lee SH; Ryu JS; Lee JJ
Ann Nucl Med; 2014 Oct; 28(8):789-95. PubMed ID: 24965850
[TBL] [Abstract][Full Text] [Related]
13. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
Santhosh S; Mittal BR; Bhasin D; Srinivasan R; Rana S; Das A; Nada R; Bhattacharya A; Gupta R; Kapoor R
J Gastroenterol Hepatol; 2013 Feb; 28(2):255-61. PubMed ID: 23278193
[TBL] [Abstract][Full Text] [Related]
14. Impact of incidental findings on integrated 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in patients with gastric cancer.
Tae CH; Lee JH; Choi JY; Min BH; Rhee PL; Kim JJ
Asia Pac J Clin Oncol; 2015 Mar; 11(1):34-40. PubMed ID: 25560093
[TBL] [Abstract][Full Text] [Related]
15. Metastatic Malignant Fibrous Histiocytoma in the Stomach: Imaging With 18F-FDG PET/CT.
Fang N; Wang YL; Zeng L; Wu ZJ; Cui XJ
Clin Nucl Med; 2016 Feb; 41(2):e123-4. PubMed ID: 26053714
[TBL] [Abstract][Full Text] [Related]
16. Incidental Detection of Urinary Leakage on FDG PET/CT Imaging for Staging of Gastric Cancer.
Kim DW; Kim MH; Kim CG
Clin Nucl Med; 2016 Mar; 41(3):217-8. PubMed ID: 26571444
[TBL] [Abstract][Full Text] [Related]
17. 18F-FLT PET/CT imaging is not competent for the pretreatment evaluation of metastatic gastric cancer: a comparison with 18F-FDG PET/CT imaging.
Zhou M; Wang C; Hu S; Zhang Y; Yao Z; Li J; Guo W; Zhang Y
Nucl Med Commun; 2013 Jul; 34(7):694-700. PubMed ID: 23604223
[TBL] [Abstract][Full Text] [Related]
18. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of thymic tumors with 18F-FDG PET-CT: a pictorial review.
Sharma P; Singhal A; Kumar A; Bal C; Malhotra A; Kumar R
Acta Radiol; 2013 Feb; 54(1):14-21. PubMed ID: 23377872
[TBL] [Abstract][Full Text] [Related]
20. ¹⁸F-FDG-PET/CT in staging, restaging, and treatment response assessment of male breast cancer.
Groheux D; Hindié E; Marty M; Espié M; Rubello D; Vercellino L; Bousquet G; Ohnona J; Toubert ME; Merlet P; Misset JL
Eur J Radiol; 2014 Oct; 83(10):1925-33. PubMed ID: 24985086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]